Improving medication adherence in advanced heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 74 years old
- Heart pumping function (ejection fraction) of 35% or lower
- Moderate-to-severe heart failure symptoms that limit daily activities (New York Heart Association class III or IV)
- Currently taking high-dose water pills (Furosemide) of more than 50 mg per day
- At least one sign that your heart failure is difficult to control, such as needing stronger medicines over time, not tolerating your current medications well, or ongoing symptoms despite advanced treatments like pacemakers or valve procedures
- Able and willing to sign a consent form and allow your medical information to be used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
This trial tests whether it is safe and effective to increase heart failure medications (like ACE inhibitors, ARBs, ARNIs, MRAs, or SGLT-2 inhibitors) without frequent kidney monitoring. It is for people with heart failure and reduced ejection fraction who are not yet on full doses of these medicines.
This study tests whether family-focused coaching and easy-to-read materials can improve heart failure medication adherence. It also uses an electronic pillbox to track how consistently you take your meds, with your care partner involved.
This trial studies a program designed to help people with heart failure improve health habits like diet, exercise, and taking medicines. It may help you feel better and stay on track if your current routines are hard to follow.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.